Lilan Yi
Impact in
-
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
-
- Lung Cancer Treatments and Mutations
- Ferroptosis and cancer prognosis
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 1
-
- Lung Cancer Treatments and Mutations 2
- Ferroptosis and cancer prognosis 1
- Co-authors
- Xiaofang Zou (7 shared papers)Guowu Wu (6 shared papers)Longhua Guo (6 shared papers)Ping Huang (2 shared papers)Jian Zhang (7 shared papers)Peng Luo (6 shared papers)Junsheng Fan (1 shared paper)Hongman Zhang (4 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Journal of Cancer (2 papers)Molecular Therapy — Nucleic Acids (1 paper)Gynecologic Oncology (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- China
In The Last Decade
Lilan Yi
13 papers receiving 369 citations
Peers
Comparison fields: 5 of 27
- Cancer Research 33
- Pulmonary and Respiratory Medicine 70
- Oncology 42
- Molecular Biology 93
- Obstetrics and Gynecology 12
Countries citing papers authored by Lilan Yi
This map shows the geographic impact of Lilan Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilan Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilan Yi more than expected).
Fields of papers citing papers by Lilan Yi
This network shows the impact of papers produced by Lilan Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilan Yi. The network helps show where Lilan Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilan Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 160 | |
| 2 | 2019 | 62 | |
| 3 | 2019 | 38 | |
| 4 | 2020 | 37 | |
| 5 | 2018 | 18 | |
| 6 | 2018 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 2018 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2019 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2021 | 0 |
About Lilan Yi
Lilan Yi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Cancer Research and Molecular Biology, having authored 14 papers that have together received 376 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Epigenetics and DNA Methylation (1 paper), Cancer Cells and Metastasis (1 paper), Ferroptosis and cancer prognosis (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), Breast Cancer Treatment Studies (1 paper) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Cancer Research (33 citations), Pulmonary and Respiratory Medicine (70 citations), Oncology (42 citations), Molecular Biology (93 citations) and Obstetrics and Gynecology (12 citations). Lilan Yi has collaborated with scholars based in China. Frequent co-authors include Xiaofang Zou, Guowu Wu, Longhua Guo, Ping Huang, Jian Zhang, Peng Luo, Junsheng Fan, Hongman Zhang, Jie Shen and Jingwen Zou. Their work appears in journals such as Frontiers in Oncology, Journal of Cancer, Molecular Therapy — Nucleic Acids, Gynecologic Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.